from the quarterly
"The feedback we have received from European markets to date indicates a need for differentiation."
so what can Anteo do to show this?
then factor's post
52810152"The Quidel Sofia test seems to have a limit of detection of 6 x 10^6. Anteo: 2.8 x 10^5 -- more than 10x more sensitive."
so we have similar sensitivity to Quidel but a much lower LOD.
and what do Quidel produce?
Quidel Corporation (NASDAQ: QDEL) (“Quidel”
, a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced the opening of a new manufacturing facility in Carlsbad, CA that will be dedicated to the production of Quidel’s popular QuickVue® line of products. The 128,000 square-foot facility will be the company’s highest-volume production plant in the world and begins operations in the second half of 2021 with a mission to produce
600 million QuickVue® SARS rapid antigen tests per year for the detection and diagnosis of COVID-19 infections.
so we have a similar test to Quidel who plan to produce 600m test this year but a much LLOD. not saying we will have the resources to match Quidel but an interesting comparison showing why we have a top5 covid test.
what else can we offer
"Cassettes can be read up to 2 hours after processing"
so if a testing station gets crowded, tests can be done and stored for up to 2 hours. so as a eg. in Australia when a person is confirmed a positive case, we do contact tracing. with our test we could collect samples from associates in the family or at work and then take them back to a central location to be tested. don't need to take a reader with you !! pretty nifty.
and lastly and most significant
our saliva test. will be ready in June, with Derek claiming it will be the most sensitive saliva test available in the market at the moment.
not bad as a selling point...
another thing that maybe getting overlooked is that Anteo have achieved all this with 5 people working on it for only a year. How good is Anteobind and our EuGeni platform?
this good. at the launch, Charlie said there are a couple of tests that can detect 1 biomarker of sepsis. we are creating a test that can detect 3 biomarkers. and if that isn't enough it will quantitatively detect how much of each is present. just think about how far advanced that is compared to a single biomarker test. and this has been done with limited stafff and funds.
what will our Eugeni platform allow to be tested once our covid test enables Anteotech to expand our team and expertise.
we are in for a ride thats for sure, as bumbly posted yesterday what will these funds enable.
View attachment 3147506
(20min delay)